natriuretic-peptide--c-type has been researched along with Multiple-Myeloma* in 2 studies
2 other study(ies) available for natriuretic-peptide--c-type and Multiple-Myeloma
Article | Year |
---|---|
The evaluation of NT-proCNP, C-reactive protein and serum amyloid A protein concentration in patients with multiple myeloma undergoing stem cell transplantation.
The importance of proinflamatory cytokines and acute phase proteins in pathogenesis and progression of MM is well known. However, there are any studies evaluating the role of NT-proCN in management and treatment of MM. The aim of our study was to evaluate the concentration of NT-proCNP and acute phase proteins in patients with MM before and after stem cell transplantation. We involved 40 newly diagnosed MM patients in stage III according to the Durie-Salmon classification and treated with high dose of melphalan (200mg/m2) prior to ASCT. Concentration of NT-proCNP, hs-CRP and SAA were measured before conditioning treatment and every 4days until the 24th day after stem cell infusion. We observed low NT-proCNP levels before conditioning treatment (0.121±0.04pmol/l), the higher in day on ASCT (0.28±0.14pmol/l). Further we showed significant gradual increase concentration of NT-proCNP up to 12days after stem cells infusion (1.07±0.72pmol/l). The kinetics of hs-CRP and SAA levels were similar to NT-proCNP. We showed positive correlation between NT-proCNP levels and absolute neutrophil and platelets count in patients after ASCT. NT-proCNP can be useful parameter to assess effectiveness of treatment and monitoring of hematopoetic recovery time in patients with MM after stem cell transplantations. Topics: Adult; C-Reactive Protein; Female; Graft Survival; Humans; Male; Middle Aged; Multiple Myeloma; Natriuretic Peptide, C-Type; Neutrophils; Platelet Count; Serum Amyloid A Protein; Stem Cell Transplantation; Time Factors; Transplantation Conditioning | 2016 |
N-terminal pro-C-type natriuretic peptide in serum associated with bone destruction in patients with multiple myeloma.
To examine whether N-terminal proCNP concentrations in serum is associated with bone destruction in patients with multiple myeloma.. N-terminal proCNP and biochemical bone markers were measured in 153 patients. Radiographic bone disease and skeletal-related events were evaluated at specific time-points.. N-terminal proCNP concentrations increased with age. High N-terminal proCNP concentrations were associated with high-risk disease and renal impairment. Renal function explained 22% of the variation. N-terminal proCNP concentrations correlated with serum bone ALP and serum PINP, but lacked association with bone resorption markers, radiographic bone disease and skeletal-related events.. Serum N-terminal proCNP are associated with bone formation activity in patients with multiple myeloma, but should be interpreted with caution in patients with renal impairment. Topics: Adult; Aged; Aged, 80 and over; Biomarkers; Bone Diseases; Female; Humans; Kaplan-Meier Estimate; Male; Middle Aged; Multiple Myeloma; Natriuretic Peptide, C-Type; Prognosis; Protein Precursors; Radiography | 2015 |